Rheumatology Doctors in Roswell, GA Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Dr. Jatin Patel, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11731 Pointe Pl, Roswell, GA 30076 Phone: 770-284-3150

Dr. Taik Kim, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11731 Pointe Pl, Roswell, GA 30076 Phone: 770-284-3150    Fax: 770-284-3170

Dr. Anil Davanand Mankee, M.B.B.S. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11731 Pointe Pl, Roswell, GA 30076 Phone: 770-284-3150

Ciela Lopez-armstrong, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1300 Upper Lembree Rd., Bld #100, Suite A, Roswell, GA 30076 Phone: 770-619-0004    Fax: 770-619-0252

News Archive

FDA approves raltegravir new HIV drug

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

FDA confirms GRAS status for Ajinomoto's AjiGRAS-Leucine

Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.

Virtual reality interface devices in reorganization of brain neural networks in neurological diseases patients

Virtual reality interface devices permit the user to interact with the virtual world in real time through a variety of multisensory channels including hearing, sight, touch and smell.

MHIF creates scientific program to address gaps in treating valvular heart disease patients

Despite significant medical advances, there continue to be significant gaps in the health care of the growing number of patients with valvular heart disease. In the USA, the total number of people aged 65 years or older with valvular heart disease will grow to approximately 5.2 million by year 2020, and 6.8 million individuals by the year 2030. The Minneapolis Heart Institute Foundation- has created a scientific program, "Valve Summit 2014: The Science and Delivery of Optimal, Multi-Disciplinary Care," to address the ongoing, complex evolution in the clinical management of patients with valvular heart disease. The conference will be held on April 25th and 26th at the Radisson Blu in downtown Minneapolis.

Read more Medical News

› Verified 5 days ago